Milestone Scientific Reports Financial Results for First Quarter 2026
Milestone Scientific reported Q1 2026 revenue of $2.16 million, a 3% decrease from the prior year, but maintained a relatively stable revenue base despite shipping challenges to the Middle East. The company significantly reduced its operating loss to $828,000, an improvement of $1.2 million from the $2.0 million loss in Q1 2025, driven by a 30% reduction in operating expenses. Management reaffirmed its outlook for 2026, expecting double-digit revenue growth of $9.8 million to $10.2 million, driven by expanding commercial adoption in both dental and medical segments.
Key figures
- Revenue
- 2162033
- Guidance
- 2026 revenue $9.8M-$10.2M, representing double-digit growth
- Revenue Yoy
- -3%
- Cash
- 1194424
- Net loss
- 839853
- Gross profit
- 1564024
- Operating loss
- 828083
- Working capital
- 2500000
- Convertible debt
- 800000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.